Process P.sup.1 for the manufacture of a secondary fatty alcohol, said process P.sup.1 comprising synthesizing an internal ketone K1 by a process P.sup.0 comprising the decarboxylative ketonization reaction of a fatty acid or the like in a liquid phase with a metal compound as catalyst in a reaction medium, wherein a ketone K.sup.2 at liquid state, which is identical or similar to the internal ketone K.sup.1, is introduced into the reaction medium, and subjecting the internal ketone K.sup.1 to a hydrogenation reaction with hydrogen gas as hydrogenating agent to form the secondary fatty alcohol. Use of the secondary fatty alcohol manufactured by the process P.sup.1 for the manufacture of an internal olefin or of an internal olefin sulfonate.

The present invention provides a fiber modifier composed of an internal olefin sulfonate having 17 or more and 24 or less carbons.

The present invention provides a fiber modifier composed of an internal olefin sulfonate having 17 or more and 24 or less carbons.

The present invention relates to a liquid detergent composition for textile products containing the following component (A) in an amount of 10% by mass or more and 60% by mass or less), the following component (B), and water: component (A): an internal olefin sulfonate having 17 or more and 24 or less carbon atoms, wherein the mass ratio of an internal olefin sulfonate having 17 or more and 24 or less carbon atoms with the sulfonate group at position 2 or higher and position 4 or lower (IO-1S) to an internal olefin sulfonate having 17 or more and 24 or less carbon atoms with the sulfonate group at position 5 or higher (IO-2S), (IO-1S)/(IO-2S), is 0.75 or more and 5.5 or less; and component (B): an organic solvent having a hydroxy group.

Presently provided are indoximod prodrug and salt compounds and pharmaceutical compositions comprising salts and prodrugs of indoximod, that produce enhanced plasma concentration and exposure to indoximod compared to direct administration of indoximod, in patients in need of treatment of immunosuppression mediated by the indoleamine-2,3-dioxygenase pathway, such as patients with cancer or chronic infectious diseases.

Presently provided are indoximod prodrug and salt compounds and pharmaceutical compositions comprising salts and prodrugs of indoximod, that produce enhanced plasma concentration and exposure to indoximod compared to direct administration of indoximod, in patients in need of treatment of immunosuppression mediated by the indoleamine-2,3-dioxygenase pathway, such as patients with cancer or chronic infectious diseases.

A method of sulfurization of fluorine-containing carbon materials obtained by heating of carbon materials in contact with fluorocarbons or fluorine-containing derivatives thereof. Claimed method allows obtaining a wide range of fluorine-containing carbon materials with grafted sulfur functionalities. Claimed materials can be used in industry as novel acid-base catalysts with high stability in any aggressive medium. Another embodiment of the invention can be used for producing electrodes of metal-sulfide batteries or as a specific sorbent, metals or nanoparticles support.

A method of sulfurization of fluorine-containing carbon materials obtained by heating of carbon materials in contact with fluorocarbons or fluorine-containing derivatives thereof. Claimed method allows obtaining a wide range of fluorine-containing carbon materials with grafted sulfur functionalities. Claimed materials can be used in industry as novel acid-base catalysts with high stability in any aggressive medium. Another embodiment of the invention can be used for producing electrodes of metal-sulfide batteries or as a specific sorbent, metals or nanoparticles support.

The present invention provides a detergent composition for textile products, containing the following component (A) and component (B): component (A): an internal olefin sulfonate having 16 or more and 18 or less carbons; and component (B): an alkyl sulfate having 12 or more and 14 or less carbons.

Described are methods and composition for inhibiting polymerization of a monomer (e.g., styrene) composition using an aminated quinone antipolymerant, such as an aminated benzoquinone or aminated naphthoquinone antipolymerant having one or more secondary or tertiary amine group(s). The aminated quinone antipolymerant can be used with little or no nitroxyl group containing antipolymerant yet still provide excellent antipolymerant activity in a monomer-containing composition.